Search results (222)
« Back to News & EventsIs now the time to rethink risk thresholds in cancer referral guidelines?
9 December 2025
A new editorial published in the British Journal of General Practice by Associate Professor Brian Nicholson examines how recent research presents an opportunity to refresh how risk thresholds are applied in national primary care cancer referral guidelines.
Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary
21 November 2025
Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of cancer research across the UK.
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
19 November 2025
People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.
PODCAST: Could vaccinations stop people from getting cancer?
12 November 2025
Professor Sarah Blagden discusses novel research approaches to cancer prevention on the Oxford Sparks podcast.
Professor Sarah Blagden to star in New Landmark Channel 4 Documentary Series 'Cancer Detectives: Finding the Cures'
16 October 2025
Channel 4 today announces 'Cancer Detectives: Finding the Cures', an observational documentary series that will explore the pioneering research that could transform the future of cancer detection, treatment and prevention.
PSA testing patterns in England raise concerns about overtesting
8 October 2025
A study of 10 million men finds many are having prostate cancer tests more frequently than recommended, with significant variations in PSA testing across England, raising concerns about overtesting.
New study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms
10 September 2025
A major UK study, led by OxCODE researchers has provided the most comprehensive analysis to date of a cancer diagnosis pathway for patients presenting with non-specific symptoms (NSS), such as unexplained weight loss or fatigue.
Platelets shown to store DNA in study that could transform cancer screening
15 August 2025
Oxford-led study uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.
Advance Your Research with the SCAN Pathway
20 July 2025
The SCAN pathway offers a unique opportunity to access one of the UK’s most comprehensive research infrastructures for non-specific cancer symptoms.
OxCODE travel awards 2025
25 June 2025
Congratulations to Zinaida Dedeic, Joshua Fieggen, Ella Mi, Shizhe Xu, Yuhan Zheng and Noushin Zibandeh who have been awarded OxCODE funds to attend this year’s major cancer prevention and early detection conferences.
New vaccines that aim to prevent cancer: Starting the conversation
11 June 2025
Bringing together academics, clinicians and members of the public to explore the possibilities and challenges of vaccines for cancer prevention.
OxCODE funding scheme awards 2025
11 June 2025
Congratulations to Adam Creamer, Pengfei Li, Francisco Lopez-Cuevas, Yuqi Shen and their collaborators who have been awarded funding in the sixth round of the OxCODE Funding Scheme.
Funding for osteosarcoma early diagnosis research
27 May 2025
The new study aims to develop a blood test that could identify markers of osteosarcoma for earlier diagnosis
New algorithms can help GPs predict which of their patients have undiagnosed cancer
12 May 2025
The algorithms use information about a person’s health conditions and simple blood tests to accurately predict a patient’s chances of having a currently undiagnosed cancer.
New guidelines published for monitoring IBD patients to prevent bowel cancer
4 May 2025
Researchers and clinicians the Universities of Oxford, Newcastle and Central Lancashire and others have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
CRUK funding for research into earlier detection of relapse in people with multiple myeloma
9 April 2025
Dr Karthik Ramasamy and team will assess a new mass spectrometry-based monitoring technique for its ability to predict and identify early disease relapse.
Daily physical activity, even at light intensities, linked to lower cancer risk
28 March 2025
A study led by Oxford researchers has found that the number of steps taken daily may be more important for lowering cancer risk than the intensity of activity.
CRUK funding for therapeutic HPV vaccine to prevent HPV-associated cancers
25 March 2025
Dr Karin Hellner is awarded a CRUK Biology to Prevention grant to undertake pre-clinical research into a broad-coverage vaccine to treat chronic human papillomavirus infection.
New biopsy technique found to improve prostate cancer detection
25 March 2025
Researchers from around the UK, led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients.
Dr David Church awarded Senior Cancer Research Fellowship from Cancer Research UK
21 March 2025
David’s research will focus on immune dysregulation in colorectal and endometrial pre-cancers and cancers.